Today · Thirsty Thursday → Members get deals first → Order ahead, skip the line →
Open daily9am – 9pm 843 Howard St · SoMa Directions → (510) 982-1460

Cannabis and cancer

What research says about cannabis for cancer symptoms, and what it can't do

Many people living with cancer ask about cannabis, usually to help with symptoms of the disease or side effects of treatment. It's a fair question, and the honest answer is more careful than a lot of what circulates online. Here is what major medical reviews say about cannabis and cancer, what is still unknown, and the risks worth raising with a care team.

Cannabis is not a cancer treatment

Lab and animal studies have looked at how cannabinoids affect cancer cells, but that work has not produced evidence that cannabis treats cancer in people. The National Cancer Institute states that the FDA has not approved cannabis or cannabinoids as a cancer treatment, and notes that it found no ongoing studies of cannabis as a cancer treatment in people (NCI). The 2017 National Academies report likewise found no or insufficient evidence to support or refute cannabinoids as a treatment for cancers, including glioma (National Academies, 2017).

In 2024 the American Society of Clinical Oncology (ASCO) published a guideline on cannabis for adults with cancer. It advises clinicians to recommend against using cannabis or cannabinoids as a cancer treatment outside a clinical trial, and strongly against using them in place of cancer treatment (ASCO, 2024). If you see claims online that cannabis oil cures cancer, no major medical body supports them.

What research shows for symptoms

Nausea and vomiting from chemotherapy

This is where the evidence is strongest. Two prescription drugs based on THC, dronabinol and nabilone, are FDA-approved for chemotherapy-related nausea and vomiting in people who haven't responded to standard anti-nausea medicine (NCI). The National Academies found conclusive or substantial evidence that oral cannabinoids are effective for this (National Academies, 2017).

There are caveats. A 2015 review of 23 studies found these drugs worked better than placebo and about as well as other anti-nausea medicines, but caused more side effects such as dizziness and sleepiness, and most of the studies date from the 1980s and 1990s, before today's anti-nausea regimens (NCCIH). ASCO's guideline says that people who still have nausea despite standard prevention may add dronabinol, nabilone, or a quality-controlled oral 1:1 THC:CBD extract to their regimen, and rates that as a weak recommendation (ASCO, 2024). Those are specific, studied preparations used alongside standard care, not a substitute for it.

Pain

The National Academies found substantial evidence that cannabis is effective for chronic pain in adults in general (National Academies, 2017). For cancer pain specifically, the picture is less clear. NCI describes study results as mixed (NCI), and ASCO concluded that evidence is insufficient to recommend for or against cannabis for cancer pain and most other treatment-related symptoms outside a clinical trial (ASCO, 2024).

Appetite and weight loss

Cannabis has a reputation for boosting appetite, but the research in cancer is weaker than that reputation. The National Academies found insufficient evidence for cannabinoids in cancer-related appetite loss and wasting (National Academies, 2017), and NCI describes a trial in people with advanced cancer where THC did no better than megestrol, a standard appetite medicine, at improving appetite or weight (NCI).

Anxiety, sleep and CBD

Evidence on anxiety and sleep in people with cancer comes mostly from small studies (NCI). In one placebo-controlled trial of 144 patients, oral CBD did no better than placebo at relieving cancer symptoms (NCI). ASCO advises against people with cancer taking 300 mg or more of CBD a day outside a trial, citing a lack of proven benefit and a risk of reversible liver enzyme problems (ASCO, 2024).

Risks to discuss with your care team

  • Side effects. NCI lists fast heartbeat, dizziness and drowsiness, and in some people depression, hallucinations or paranoia (NCI). These can add to the fatigue and fogginess some cancer treatments already cause.
  • Drug interactions. ASCO notes that cannabinoids can change how the body processes some medicines. It flags warfarin as a very high-risk interaction and points out that many chemotherapy drugs are processed by the same liver enzymes (ASCO, 2024).
  • Immunotherapy. Observational studies suggest people who use cannabis may benefit less from immunotherapy (NCI). That isn't proven, but it is a good reason to talk with your oncologist before using cannabis during treatment.
  • Smoking. The National Academies found substantial evidence that long-term cannabis smoking is linked to worse respiratory symptoms and more frequent bronchitis (National Academies, 2017).
  • Dependence. NCI notes that cannabis can be addictive and that withdrawal symptoms can occur, though they are mild compared with opioid withdrawal (NCI).

Talk to your doctor

ASCO's guideline asks cancer clinicians to ask about cannabis use routinely and without judgment (ASCO, 2024), so there is no need to keep it from your care team. Tell your oncologist about any cannabis or CBD you use or are considering, including how much, so they can check it against your treatment plan. Never use cannabis in place of the cancer treatment your doctor recommends, and don't change a prescribed treatment without talking to them first.

This article is general information, not medical advice.

Sources

  1. National Cancer Institute. Cannabis and Cannabinoids (PDQ®)–Patient Version. Updated 2023. https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq
  2. Braun IM, et al. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. Journal of Clinical Oncology, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11730458/
  3. National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press, 2017. https://www.nationalacademies.org/read/24625/chapter/2
  4. National Center for Complementary and Integrative Health (NIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know. 2019. https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
Written by Michael Nolin

Michael Nolin writes The Green Door's guides on how cannabis affects the body, with the research behind them.

More from Michael Nolin →